The primary purpose of the study is to determine if IVT injections of vonaprument every month reduce vision loss in participants with dry AMD with GA.

Inclusion Criteria:

• Diagnosis of dry AMD with GA as determined by the Investigator and confirmed by the independent Central Reading Center.

Exclusion Criteria:

• Geographic atrophy due to other causes than AMD such as Stargardt disease, cone-rod dystrophy, pathologic myopia, or toxic maculopathies (for example, plaquenil maculopathy) in either eye.

NOTE: Other protocol-defined inclusion and exclusion criteria apply.